Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 24, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Head and Neck CancerLocally Advanced Head and Neck Carcinoma

Interventions

DRUG

Gabapentin

Taken by mouth 3 times per day

DRUG

Ketamine

Administered intranasally 3 times per day

Trial Locations (1)

RECRUITING

Vanderbilt-Ingram Cancer Center, Nashville

All Listed Sponsors

lead

Natalie Lockney

OTHER